DE69227623D1 - Verfahren zum Nachweis einer CMV-Infektion - Google Patents

Verfahren zum Nachweis einer CMV-Infektion

Info

Publication number
DE69227623D1
DE69227623D1 DE69227623T DE69227623T DE69227623D1 DE 69227623 D1 DE69227623 D1 DE 69227623D1 DE 69227623 T DE69227623 T DE 69227623T DE 69227623 T DE69227623 T DE 69227623T DE 69227623 D1 DE69227623 D1 DE 69227623D1
Authority
DE
Germany
Prior art keywords
cmv infection
detection
procedure
cd45ra
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69227623T
Other languages
English (en)
Other versions
DE69227623T2 (de
Inventor
Thomas Totterman
Erland Hanas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69227623D1 publication Critical patent/DE69227623D1/de
Publication of DE69227623T2 publication Critical patent/DE69227623T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
DE69227623T 1992-04-10 1992-04-10 Verfahren zum Nachweis einer CMV-Infektion Expired - Fee Related DE69227623T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92303259A EP0564735B1 (de) 1992-04-10 1992-04-10 Verfahren zum Nachweis einer CMV-Infektion

Publications (2)

Publication Number Publication Date
DE69227623D1 true DE69227623D1 (de) 1998-12-24
DE69227623T2 DE69227623T2 (de) 1999-05-20

Family

ID=8211327

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227623T Expired - Fee Related DE69227623T2 (de) 1992-04-10 1992-04-10 Verfahren zum Nachweis einer CMV-Infektion

Country Status (4)

Country Link
EP (1) EP0564735B1 (de)
AT (1) ATE173543T1 (de)
DE (1) DE69227623T2 (de)
ES (1) ES2125248T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454515A1 (en) * 2001-07-25 2003-02-06 Mitsubishi Pharma Corporation Cancer diagnostics
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
CN102203133B (zh) 2008-07-16 2015-01-07 生物医学研究学会 人巨细胞病毒中和抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745285A (en) * 1986-08-21 1988-05-17 Becton Dickinson And Company Multi-color fluorescence analysis with single wavelength excitation
FI105320B (fi) * 1988-04-04 2000-07-31 Oncogen Menetelmä vasta-aineheterokonjugaattien valmistamiseksi, joita käytetään imusoluaktiivisuuden säätelyssä ja diagnoosissa

Also Published As

Publication number Publication date
DE69227623T2 (de) 1999-05-20
ATE173543T1 (de) 1998-12-15
ES2125248T3 (es) 1999-03-01
EP0564735B1 (de) 1998-11-18
EP0564735A1 (de) 1993-10-13

Similar Documents

Publication Publication Date Title
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
DE69513649D1 (de) Verfahren zum nachweis der gegenwart einer mykobakterien-spezies und testsatz sowie antikörpes zur verwendung in diesem verfahren
DE69227623D1 (de) Verfahren zum Nachweis einer CMV-Infektion
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
AU635243B2 (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
BR9100924A (pt) Linha de celulas de hibridoma,mutantes,anticorpos,processo para a preparacao de uma linha de celulas de hibridoma,processo para a preparacao de anticorpos,processo e agente para a prova imunologica de metolacloro,derivado de metolacloro e processo para sua preparacao
DE3587542T2 (de) Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren.
ATE80467T1 (de) Immuntestverfahren.
ATE76974T1 (de) Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden.
DE3874741T2 (de) Immunassay-verfahren.
GB9403215D0 (en) Chemical modification of antibodies and antigens
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
ATE80226T1 (de) Verfahren zum nachweis von einer infektion oder entzuendung des harnbezueglichen tractus.
DE3863270D1 (de) Immuntest.
DK0556281T3 (da) Diagnoseassay for Lyme sygdom
ATE110470T1 (de) Immuntestverfahren von chondrocalcin.
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente
IT1226700B (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee